Prosperity Consulting Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$800K Buy
2,209
+370
+20% +$127K 0.03% 302
2026
Q1
$647K Buy
1,839
+56
+3% +$20K 0.03% 315
2025
Q4
$584K Sell
1,783
-485
-21% -$154K 0.03% 336
2025
Q3
$640K Buy
2,268
+75
+3% +$21.8K 0.03% 308
2025
Q2
$612K Sell
2,193
-3,052
-58% -$865K 0.04% 283
2025
Q1
$1.63M Buy
5,245
+47
+0.9% +$13.9K 0.13% 168
2024
Q4
$1.35M Buy
5,198
+131
+3% +$38.9K 0.1% 193
2024
Q3
$1.63M Sell
5,067
-839
-14% -$274K 0.13% 176
2024
Q2
$1.85M Sell
5,906
-106
-2% -$31.1K 0.25% 105
2024
Q1
$1.71M Buy
6,012
+135
+2% +$39.5K 0.21% 114
2023
Q4
$1.69M Buy
5,877
+213
+4% +$58K 0.57% 40
2023
Q3
$1.52M Buy
+5,664
New +$1.41M 0.7% 34

Other funds holding AMGN

Prosperity Consulting Group's AMGN Position: Q2 2026 in Review

Prosperity Consulting Group increased its Amgen (AMGN) stake by 20% in Q2 2026, buying an estimated $127K and bringing the position to 2,209 shares worth $800K. The position accounts for 0.03% of the portfolio, ranked #302.

Prosperity Consulting Group first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.85M in Q2 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Prosperity Consulting Group held 2,209 shares of Amgen worth $800K as of Q2 2026.
  • Prosperity Consulting Group bought 370 Amgen shares in Q2 2026, an estimated $127K.
  • Amgen made up 0.03% of Prosperity Consulting Group's portfolio in Q2 2026, its #302 holding.
  • Prosperity Consulting Group first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Prosperity Consulting Group's Amgen position peaked at $1.85M in Q2 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.